Comparative assessment of ocular tissue distribution of drug-related radioactivity after chronic oral administration of 14C-levofloxacin and 14C-chloroquine in pigmented rats

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 8, 2004, Pages 977-983

  Tanaka, Makoto ^a   Takashina, Hideo ^b   Tsutsumi, Shuichiro ^c  

^a DAIICHI SANKYO CO   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

^c DAIICHI PURE CHEMICALS CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CHLOROQUINE; LEVOFLOXACIN; MELANIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CHOROID; CILIARY BODY; CONTROLLED STUDY; CORNEA; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG TISSUE LEVEL; EYE TOXICITY; IRIS; LENS; LONG TERM EXPOSURE; MALE; MULTIPLE DRUG DOSE; NONHUMAN; PIGMENT EPITHELIUM; RADIOACTIVITY; RAT; RETINA; SCLERA; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMALARIALS; CHEMISTRY, PHARMACEUTICAL; CHLOROQUINE; MALE; OFLOXACIN; RATS; TISSUE DISTRIBUTION; UVEA;

EID: 4344630864     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357043932     Document Type: Article

References (23)

1. Böke, W., Bäumer, A., Müller-Limmroth, W., Mludeck, M. (1967) Zur Frage der Chloroquinschädigung des Auges. Klin. Monatsbl. Augenheilkd. 151: 617-633
2. Fukuda, M., Sasaki, K. (1989) Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes. Lens Eye Toxic. Res. 6: 339-351
3. Fukuda, M., Sasaki, K. (1990) Changes in the antibacterial activity of melanin-bound drugs. Ophthalmic Res. 22: 123-127
4. Fukuda, M., Morita, Y., Sasaki, K., Yamamoto, Y. (2000) Studies on the binding mechanism of fluoroquinolones to melanin. J. Infect. Chemother. 6: 72-76
5. Goldman, L., Preston, R. H. (1957) Reactions to chloroquine observed during the treatment of various dermatologic disorders. Am. J. Trop. Med. Hyg. 6: 654-657
6. Hobbs, H. E., Sorsby, A., Freedman, A. (1959) Retinopathy following chloroquine therapy. Lancet 2: 478-480
7. Hurst, M., Lamb, H. M., Scott, L. J., Figgitt, D. P. (2002) Levofloxacin: an updated review of its use in the treatment of bacterial infections. Drugs 62: 2127-2167
8. Ings, R. M. J. (1984) The melanin binding of drugs and its implications, Drug Metab. Rev. 15: 1183-1212
9. Jones, S. K. (1999) Ocular toxicity and hydroxychloroquine: guidelines for screening. Br. J. Dermatol. 140: 3-7
10. Kasuya, Y., Miyata, H., Watanabe, M. (1976) Toxicological studies on the chloroquine-melanin affinity in vivo and in vitro in relation to the chloroquine retinopathy. J. Toxicol. Sci. 1: 30-38
11. Kurata, T., Aoki, H., Okazaki, O., Hakusui, H., Esumi, Y., Mitsugi, K., Katami, Y., Watanabe, I., Ohbu, Y., Okada, M. (1991) The pharmacokinetics of DR-3355 (IV): absorption, distribution and excretion after a single oral administration to monkeys. Xenobio. Metabol. Dispos. 6: 143-152
12. Larsson, B. S. (1993) Interaction between chemicals and melanin. Pigment Cell Res. 6: 127-133
13. Larsson, B., Tjälve, H. (1979) Studies on the mechanism of drug-binding to melanin. Biochem. Pharmacol. 28: 1181-1187
14. Leblanc, B., Jezequel, S., Davies, T., Hanton, G., Taradach, C. (1998) Binding of drugs to eye melanin is not predictive of ocular toxicity. Regul. Toxicol. Pharmacol. 28: 124-132
15. Lindquist, N. G., Ullberg, S. (1972) The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography. Acta Pharmacol. Toxicol. 31 (Suppl. II): 3-32
16. Ono, C., Tanaka, M. (2003) Binding characteristics of fluoroquinolones to synthetic levodopa melanin. J. Pharm. Pharmacol. 55: 1127-1133
17. 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in vivo J. Pharm. Pharmacol. 55: 1647-1654
18. Perez, S., Solans, C., Bregante, M. A., Pinilla, I., Garcia, M. A., Honrubia, F. (2002) Pharmacokinetics and ocular penetration of grepafloxacin in albino and pigmented rabbits. J. Antimicrob. Chemother. 50: 541-545
19. Salazar-Bookaman, M. M., Wainer, I., Patil, P. N. (1994) Relevance of drug-melanin interactions to ocular pharmacology and toxicology. J. Ocul. Pharmacol. 10: 217-239
20. Siefert, H. M., Kohlsdorfer, C., Steinke, W., Witt, A. (1999) Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. J. Antimicrob. Chemother. 43 (Suppl. B): 61-67
21. Stepien, K. B., Wilczok, T. (1982) Studies of the mechanism of chloroquine binding to synthetic dopa-melanin. Biochem. Pharmacol. 31: 3359-3365
22. 14C-levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin-related radioactivity to melanin in vivo. J. Pharm. Pharmacol. 56: 463-469
23. Tjälve, H., Nilsson, M., Larsson, B. (1981) Studies on the binding of chlorpromazine and chloroquine to melanin in vivo. Biochem. Pharmacol. 30: 1845-1847